Align Technology Sees iTero Revenue Rebound in 2027 After Pricing Cuts Outlook

Align Technology logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Align expects iTero revenue to return to growth in 2027, after pricing discounts and a shift toward lower-priced configurations, leasing, and rentals reduced its 2026 sales outlook. Scanner demand remains strong, with unit sales up and the installed base growing by double digits.
  • The company reiterated its goal of 100 basis points of adjusted operating margin improvement in 2027, supported by manufacturing efficiencies, higher-margin products, and tighter operating expenses.
  • Align said lower-upfront-cost Zero AA products grew by triple digits year over year and helped keep aligner average selling prices roughly flat, while making treatment more accessible to cost-conscious consumers.
  • MarketBeat previews the top five stocks to own by December 1st.

Align Technology NASDAQ: ALGN expects its iTero scanner business to return to revenue growth in 2027 after pricing discounts and product mix contributed to a reduction in its 2026 sales outlook, executives said at the Jefferies Global Healthcare Conference in London.

CFO John Morici said scanner unit sales have been strong and the installed base has grown by double digits, even as iTero revenue declined year over year in the third quarter. CEO Joe Hogan said Invisalign sales performed relatively well during the period, despite continued pressure on consumers facing largely out-of-pocket orthodontic costs.

Hogan also discussed his planned retirement and the transition to incoming CEO Jennifer Davis. The succession process involved a review of candidates over approximately a year and a half, he said, and the transition is expected to conclude through December.

Scanner Pricing and 2027 Outlook

Morici said most of the adjustment to Align’s 2026 sales guidance reflected iTero pricing and mix, rather than a lack of scanner demand. Discounts have helped drive placements, he said, while some customers have chosen lower-priced configurations or shifted toward leasing and renting.

For 2027, Morici said the company expects like-for-like scanner pricing to remain stable, although changes in product and financing mix could affect reported average selling prices. He expects iTero revenue to grow next year, though potentially at a slower pace than Invisalign, depending in part on the capital equipment market and conditions in doctors’ practices.

Align has not yet issued 2027 guidance. Morici said the company plans to provide an update after the fourth quarter that reflects market conditions and its efforts to support growth.

The CFO reiterated a goal of 100 basis points of adjusted operating margin improvement in 2027, assuming no meaningful change in the consumer environment. He expects the improvement to be more balanced between gross margin and operating expenses than it has been this year.

Products requiring fewer refinements carry higher gross margins, Morici said. He also cited savings from manufacturing changes, including production closer to customers, and efforts to improve operating expense productivity.

Lower-Cost Aligner Options and China

Executives said lower-upfront-cost products and patient financing are helping doctors reach consumers who may be reluctant to begin treatment. Morici said Align’s Zero AA products grew by triple digits year over year and were attracting greater use rather than merely shifting demand from other Align products.

He said the product has helped the company maintain aligner average selling prices, which were approximately flat year over year through October. Align did not disclose what percentage of its cases use Zero AA.

Asked about potential volume-based procurement, or VBP, for orthodontics in China, Hogan said it remains uncertain whether such a program will be introduced. He said approximately 85% of Align’s China business is private and that the company has manufacturing and treatment-planning operations in the country.

Morici said China accounts for less than 10% of company revenue and that clear aligners represent less than 10% of that market. A procurement program could bring price pressure as well as additional volume, he said, adding that the company has considered the possibility in its 2027 planning.

Sports Guards and CEO Transition

Hogan described the Invisalign Sports Guard as an extension of Align’s 3D-printing technology and a potential way for doctors to connect with younger patients. Morici said the company is seeing demand from doctors interested in offering the product.

Hogan compared the opportunity with Align’s approximately $500 million retainer business, saying he saw no reason the sports guard business could not reach a similar range over time. He also expressed confidence in Davis, citing her experience at Procter & Gamble and their work together during the transition.

About Align Technology (NASDAQ:ALGN)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Align Technology Right Now?

Before you consider Align Technology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.

While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines